103404-57-5 Usage
Uses
Used in Pharmaceutical Industry:
1,2,3-Heptanetriol is used as a pharmaceutical intermediate for the synthesis of various drugs and medications. Its unique structure allows it to be a versatile building block in the development of new pharmaceutical compounds.
Used in Cosmetic Industry:
1,2,3-Heptanetriol is used as a moisturizing agent in the cosmetic industry. Its hydroxy groups help to retain moisture in the skin, providing hydration and improving skin texture.
Used in Chemical Synthesis:
1,2,3-Heptanetriol is used as a key intermediate in the synthesis of various organic compounds, including fine chemicals, specialty chemicals, and other complex molecules.
Used in Research and Development:
1,2,3-Heptanetriol is utilized in research and development for studying its properties and potential applications in various fields, such as material science, biotechnology, and pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 103404-57-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,3,4,0 and 4 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 103404-57:
(8*1)+(7*0)+(6*3)+(5*4)+(4*0)+(3*4)+(2*5)+(1*7)=75
75 % 10 = 5
So 103404-57-5 is a valid CAS Registry Number.
InChI:InChI=1/C7H16O3/c1-2-3-4-6(9)7(10)5-8/h6-10H,2-5H2,1H3/t6-,7-/m0/s1
103404-57-5Relevant academic research and scientific papers
DERMATOLOGICAL COMPOSITIONS AND METHODS
-
, (2008/06/13)
Disclosed are methods and compositions for regulating the melanin content of mammalian melanocytes; regulating pigmentation in mammalian skin, hair, wool or fur; treating or preventing various skin and proliferative disorders; by administration of various compounds, including alcohols, diols and/or triols and their analogues.
Treatment of neurodegenerative diseases
-
, (2008/06/13)
Disclosed are methods for increasing the differentiation of mammalian neuronal cells for purposes of treating neurodegenerative diseases or nerve damage by administration of various compounds including alcohols, diols and/or triols and their analogues.
Treatment of diseases mediated by the nitric oxide/cGMP/protein kinase G pathway
-
, (2008/06/13)
Disclosed are methods and compositions for stimulating cellular nitric oxide (NO) synthesis, cyclic guanosine monophosphate levels (cGMP), and protein kinase G (PKG) activity for purposes of treating diseases mediated by deficiencies in the NO/cGMP/PKG signal transduction pathway, by administration of various compounds including alcohols, diols and/or triols and their analogues.
